Targeting the p-D-C: easy as C-D-1-2-3?

Naveen Pemmaraju

doi:10.1182/blood.2020008745

Targeting the p-D-C: easy as C-D-1-2-3?

Naveen Pemmaraju

Leukemia

Research output: Contribution to journal › Editorial › peer-review

9 Scopus citations

Original language	English (US)
Pages (from-to)	1277-1278
Number of pages	2
Journal	Blood
Volume	137
Issue number	10
DOIs	https://doi.org/10.1182/blood.2020008745
State	Published - Mar 11 2021

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2020008745

Cite this

@article{56fae774b0ee42e4a861fda6df9095dd,

title = "Targeting the p-D-C: easy as C-D-1-2-3?",

author = "Naveen Pemmaraju",

note = "Funding Information: Conflict-of-interest disclosure: The author reports consulting/honorarium from Celgene, Stemline, Incyte, Novartis, MustangBio, Roche Diagnostics, LFB, Pacylex, Blueprint Medicines, and Abbvie; and research funding/clinical trials support from Stemline, Novartis, Abbvie, Samus, Cellectis, Plexxikon, Daiichi-Sankyo, Affymetrix, and SagerStrong Foundation. ",

year = "2021",

month = mar,

day = "11",

doi = "10.1182/blood.2020008745",

language = "English (US)",

volume = "137",

pages = "1277--1278",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "10",

}

TY - JOUR

T1 - Targeting the p-D-C

T2 - easy as C-D-1-2-3?

AU - Pemmaraju, Naveen

N1 - Funding Information: Conflict-of-interest disclosure: The author reports consulting/honorarium from Celgene, Stemline, Incyte, Novartis, MustangBio, Roche Diagnostics, LFB, Pacylex, Blueprint Medicines, and Abbvie; and research funding/clinical trials support from Stemline, Novartis, Abbvie, Samus, Cellectis, Plexxikon, Daiichi-Sankyo, Affymetrix, and SagerStrong Foundation.

PY - 2021/3/11

Y1 - 2021/3/11

UR - http://www.scopus.com/inward/record.url?scp=85102604879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102604879&partnerID=8YFLogxK

U2 - 10.1182/blood.2020008745

DO - 10.1182/blood.2020008745

M3 - Editorial

C2 - 33704391

AN - SCOPUS:85102604879

SN - 0006-4971

VL - 137

SP - 1277

EP - 1278

JO - Blood

JF - Blood

IS - 10

ER -

Targeting the p-D-C: easy as C-D-1-2-3?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this